Assembly Actions - Lowercase Senate Actions - UPPERCASE |
|
---|---|
Mar 26, 2018 | referred to insurance delivered to senate passed assembly |
Jan 03, 2018 | ordered to third reading cal.567 returned to assembly died in senate |
Jun 21, 2017 | referred to rules delivered to senate passed assembly |
Jun 20, 2017 | ordered to third reading rules cal.617 rules report cal.617 reported reported referred to rules reported referred to codes |
Jun 08, 2017 | print number 7979a |
Jun 08, 2017 | amend and recommit to insurance |
May 23, 2017 | referred to insurance |
Archive: Last Bill Status - Passed Assembly
- Introduced
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed/Vetoed by Governor
Your Voice
Actions
Bill Amendments
A7979 - Details
- See Senate Version of this Bill:
- S6674
- Current Committee:
- Senate Insurance
- Law Section:
- Insurance Law
- Laws Affected:
- Amd §§3216, 3221 & 4303, rpld §3216 sub§ (i) ¶31-a, §3221 sub§ (l) ¶¶7-a & 7-b, §4303 sub§§ (l-1) & (l-2), Ins L
- Versions Introduced in 2019-2020 Legislative Session:
-
A2904, S4808
A7979 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 7979 2017-2018 Regular Sessions I N A S S E M B L Y May 23, 2017 ___________ Introduced by M. of A. QUART -- read once and referred to the Committee on Insurance AN ACT to amend the insurance law, in relation to prohibiting certain insurance policies from requiring prior authorization for certain medications used in the treatment of substance use disorders; and to repeal certain provisions of such law relating thereto THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Paragraph 31-a of subsection (i) of section 3216 of the insurance law is REPEALED and a new paragraph 31-a is added to read as follows: (31-A) (A) NO POLICY THAT PROVIDES MEDICAL, MAJOR MEDICAL OR SIMILAR COMPREHENSIVE-TYPE COVERAGE AND PROVIDES COVERAGE FOR PRESCRIPTION DRUGS FOR MEDICATION FOR THE TREATMENT OF A SUBSTANCE USE DISORDER SHALL REQUIRE PRIOR AUTHORIZATION FOR AN INITIAL OR RENEWAL PRESCRIPTION FOR ALL BUPRENORPHINE PRODUCTS OR LONG ACTING INJECTABLE NALTREXONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT OF A SUBSTANCE USE DISORDER EXCEPT WHERE OTHERWISE PROHIBITED BY LAW. (B) COVERAGE PROVIDED UNDER THIS PARAGRAPH MAY BE SUBJECT TO COPAY- MENTS, COINSURANCE, AND ANNUAL DEDUCTIBLES THAT ARE CONSISTENT WITH THOSE IMPOSED ON OTHER BENEFITS WITHIN THE POLICY. § 2. Paragraphs 7-a and 7-b of subsection (l) of section 3221 of the insurance law are REPEALED and a new paragraph 7-a is added to read as follows: (7-A) (A) EVERY POLICY THAT PROVIDES MEDICAL, MAJOR MEDICAL OR SIMILAR COMPREHENSIVE-TYPE LARGE GROUP COVERAGE SHALL PROVIDE IMMEDIATE COVERAGE FOR ALL BUPRENORPHINE PRODUCTS OR LONG ACTING INJECTABLE NALTREXONE WITHOUT PRIOR AUTHORIZATION FOR THE DETOXIFICATION OR MAINTENANCE TREAT- MENT OF A SUBSTANCE USE DISORDER. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD11793-01-7
Co-Sponsors
Luis R. Sepúlveda
A7979A (ACTIVE) - Details
- See Senate Version of this Bill:
- S6674
- Current Committee:
- Senate Insurance
- Law Section:
- Insurance Law
- Laws Affected:
- Amd §§3216, 3221 & 4303, rpld §3216 sub§ (i) ¶31-a, §3221 sub§ (l) ¶¶7-a & 7-b, §4303 sub§§ (l-1) & (l-2), Ins L
- Versions Introduced in 2019-2020 Legislative Session:
-
A2904, S4808
A7979A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 7979--A 2017-2018 Regular Sessions I N A S S E M B L Y May 23, 2017 ___________ Introduced by M. of A. QUART -- read once and referred to the Committee on Insurance -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the insurance law, in relation to prohibiting certain insurance policies from requiring prior authorization for certain medications used in the treatment of substance use disorders; and to repeal certain provisions of such law relating thereto THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Paragraph 31-a of subsection (i) of section 3216 of the insurance law is REPEALED and a new paragraph 31-a is added to read as follows: (31-A) (A) NO POLICY THAT PROVIDES MEDICAL, MAJOR MEDICAL OR SIMILAR COMPREHENSIVE-TYPE COVERAGE AND PROVIDES COVERAGE FOR PRESCRIPTION DRUGS FOR MEDICATION FOR THE TREATMENT OF A SUBSTANCE USE DISORDER SHALL REQUIRE PRIOR AUTHORIZATION FOR AN INITIAL OR RENEWAL PRESCRIPTION FOR ALL BUPRENORPHINE PRODUCTS, METHADONE OR LONG ACTING INJECTABLE NALTREX- ONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT OF A SUBSTANCE USE DISORDER EXCEPT WHERE OTHERWISE PROHIBITED BY LAW. (B) COVERAGE PROVIDED UNDER THIS PARAGRAPH MAY BE SUBJECT TO COPAY- MENTS, COINSURANCE, AND ANNUAL DEDUCTIBLES THAT ARE CONSISTENT WITH THOSE IMPOSED ON OTHER BENEFITS WITHIN THE POLICY. § 2. Paragraphs 7-a and 7-b of subsection (l) of section 3221 of the insurance law are REPEALED and a new paragraph 7-a is added to read as follows: (7-A) (A) EVERY POLICY THAT PROVIDES MEDICAL, MAJOR MEDICAL OR SIMILAR COMPREHENSIVE-TYPE LARGE GROUP COVERAGE SHALL PROVIDE IMMEDIATE COVERAGE FOR ALL BUPRENORPHINE PRODUCTS, METHADONE OR LONG ACTING INJECTABLE NALTREXONE WITHOUT PRIOR AUTHORIZATION FOR THE DETOXIFICATION OR MAINTE- NANCE TREATMENT OF A SUBSTANCE USE DISORDER. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD11793-02-7